Choroidal thinning in diabetes type 1 detected by 3- dimensional 1060 nm optical coherence tomography

Investigative Ophthalmology and Visual Science

Volumn 53, Issue 11, 2012, Pages 6803-6809

  Esmaeelpour, Marieh ^a,b   Brunner, Simon ^a   Ansari Shahrezaei, Siamak ^a   Nemetz, Susanne ^c   Povâzay, Boris ^b   Kajic, Vedran ^b   Drexler, Wolfgang ^b   Binder, Susanne ^a  

^a LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c Optique Nemetz   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CHOROIDAL THINNING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; OPTICAL COHERENCE TOMOGRAPHY; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINA FOVEA; RETINAL THICKNESS; TOPOGRAPHY; VISUAL SYSTEM PARAMETERS; CHOROID; COMPARATIVE STUDY; DIABETIC RETINOPATHY; DIFFERENTIAL DIAGNOSIS; METHODOLOGY; MIDDLE AGED; PATHOLOGY; REPRODUCIBILITY; THREE DIMENSIONAL IMAGING;

ADULT; CHOROID; DIABETES MELLITUS, TYPE 1; DIABETIC RETINOPATHY; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMAGING, THREE-DIMENSIONAL; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; TOMOGRAPHY, OPTICAL COHERENCE; YOUNG ADULT;

EID: 84871880036     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.12-10314     Document Type: Article

References (31)

1. Laakso M. Epidemiology of type 2 diabetes. In: Goldstein BJ, Mueller-Wieland D, eds. Type 2 Diabetes: Principles and Practice. 2nd ed. New York, NY: Country Informa Healthcare; 2007:1-12.
2. American Diabetes Association. Standards of Medical Care in Diabetes-2011. Diabetes Care. 2011;34(Suppl 1):S11-S61.
3. Nathan DM, Zinman B, Cleary PA, et al. Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (1983-2005). Arch. Intern. Med. 2009;169:1307-1316.
4. Klein R, Knudtson MD, Lee KE, Gangnon R, Klein BEK. The Wisconsin Epidemiologic Study of Diabetic Retinopathy XXIII: the twenty-five-year incidence of macular edema in persons with type 1 diabetes. Ophthalmology. 2009;116:497-503.
5. Bresnick GH. Diabetic macular edema. A review. Ophthalmology. 1986;93:989-997.
6. Aiello LP, Gardner TW, King GL, et al. Diabetic retinopathy. Diabetes Care. 1998;21:143-156.
7. Trudeau K, Molina AJA, Guo W, Roy S. High glucose disrupts mitochondrial morphology in retinal endothelial cells: implications for diabetic retinopathy. Am. J. Pathol. 2010;177:447-455.
8. Ciulla TA, Harris A, Latkany P, et al. Ocular perfusion abnormalities in diabetes. Acta Ophthalmol Scand. 2002;80: 468-477.
9. Schocket LS, Brucker AJ, Niknam RM, et al. Foveolar choroidal hemodynamics in proliferative diabetic retinopathy. Int Ophthalmol. 2004;25:89-94.
10. Esmaeelpour M, Povazay B, Hermann B, et al. Mapping choroidal and retinal thickness variation in type 2 diabetes using 3-dimensional 1060-nm optical coherence tomography. Invest Ophthalmol Vis Sci. 2011;52:5311-5316.
11. Kajić V, Esmaeelpour M, Považay B, et al. Automated choroidal segmentation of 1060 nm OCT in healthy and pathologic eyes using a statistical model. Biomed Opt Express. 2011;3:86-103.
12. Anon. Grading diabetic retinopathy from stereoscopic color fundus photographs-an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology. 1991;98:786-806.
13. Safe Use of Lasers & Safe Use of Optical Fiber Communications. New York, NY: American National Standard Institute-Z136 Committee; 2000.
14. Revision of the Guidelines on Limits of Exposure to Laser Radiation of Wavelengths between 400nm and 1.4lm. Munich, Germany: International Commission on Non-Ionizing Radiation Protection; 2000.
15. Esmaeelpour M, Povazay B, Hermann B, et al. Three-dimensional 1060nm OCT: Choroidal thickness maps in normals and improved posterior segment visualization in cataract patients. Invest. Ophthalmol. Vis. Sci. 2010;51:5260-5266.
16. Kajić V, Povazay B, Hermann B, et al. Robust segmentation of intraretinal layers in the normal human fovea using a novel statistical model based on texture and shape analysis. Opt Express. 2010;18:14730-14744.
17. ACCCORD Study Group. Effects of Medical Therapies on Retinopathy Progression in Type 2 Diabetes. N Engl J Med. 2010;363:233-244.
18. Keech AC, Mitchell P, Summanen PA, et al. Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial. Lancet. 2007;370:1687-1697.
19. Nguyen QD, Shah SM, Khwaja AA, et al. Two-year outcomes of the ranibizumab for edema of the macula in diabetes (READ-2) study. Ophthalmology. 2010;117:2146-2151.
20. Pearson PA, Comstock TL, Ip M, et al. Fluocinolone acetonide intravitreal implant for diabetic macular edema: a 3-year multicenter, randomized, controlled clinical trial. Ophthalmology. 2011;118:1580-1587.
21. Anon. Treatment techniques and clinical guidelines for photocoagulation of diabetic macular edema. Early Treatment Diabetic Retinopathy Study Report Number 2. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology. 1987;94:761-774.
22. McLeod DS, Lutty GA. High-resolution histologic analysis of the human choroidal vasculature. Invest Ophthalmol Vis Sci 1994;35:3799-3811.
23. Cavallotti C, Cerulli L. Age-Related Changes Of The Human Eye. Totowa, NJ: Humana Press; 2008:217.
24. Dobree JH. Simple diabetic retinopathy. Evolution of the lesions and therapeutic considerations. Br J Ophthalmol. 1970;54:1-10.
25. Gass JM. Fluorescein angiographie study of macular dysfunction secondary to retinal vascular disease. IV. Diabetic retinal angiopathy. Arch Ophthalmol. 1968;80:581-591.
26. Lahrmann C, Bek T. Foveal haemorrhages in diabetic retinopathy. Clinical characteristics and visual outcome. Acta Ophthalmologica Scandinavica. 2001;78:169-172.
27. Lobo CL, Bernardes RC, Cunha-Vaz JG. Alterations of the blood-retinal barrier and retinal thickness in preclinical retinopathy in subjects with type 2 diabetes. Arch Ophthalmol. 2000;118:1364-1369.
28. Bronson-Castain KW, Bearse MA Jr, Neuville J, et al. Early neural and vascular changes in the adolescent type 1 and type 2 diabetic retina. Retina (Philadelphia, Pa.). 2012;32: 92-102.
29. Klein R, Klein BEK, Moss SE, et al. The relation of retinal vessel caliber to the incidence and progression of diabetic retinopathy: XIX: the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Arch. Ophthalmol. 2004;122:76-83.
30. Soliman W, Sander B, Soliman KA, et al. The predictive value of optical coherence tomography after grid laser photocoagulation for diffuse diabetic macular oedema. Acta Ophthalmol. 2008;86:284-291.
31. Baskin DE. Optical coherence tomography in diabetic macular edema. Curr Opin Ophthalmol. 2010;21:172-177.